Heart Failure Management in Azerbaijan (CHF-AZ)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03390088|
Recruitment Status : Recruiting
First Posted : January 4, 2018
Last Update Posted : July 10, 2019
|Condition or disease|
Chronic heart failure remains the leading cause of hospitalization for those over the age of 65 and expected to increase over the next 25 years with advancing life span. Being a progressive syndrome, CHF decreases the quality of life and place an economic burden on health care system.
Advanced technologies in interventional cardiology, better organization of angiographic laboratories and primary prevention of coronary artery disease as the leading cause of HF, allowed warning its development in CAD patients. But the incidence and prevalence of CHF continue to increase with age as heart failure with preserved ejection fraction predominates in elderly patients. For the moment more than 23 million people over the world suffer from heart failure.
The prevalence of these patients remains very high even in USA - over 5.8 million.However, there is no any database for heart failure patient in Azerbaijan.The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests and management of outpatients heart failure in Azerbaijan population.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||The Clinical Profiles and Treatment Management of Chronic Heart Failure in Azerbaijan|
|Actual Study Start Date :||January 28, 2018|
|Estimated Primary Completion Date :||December 28, 2019|
|Estimated Study Completion Date :||January 14, 2020|
- Heart failure related hospitalization [ Time Frame: 6 months ]Heart failure related hospitalization within 6 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03390088
|Contact: Yasmin Rustamova, MD, PhD||+99450 firstname.lastname@example.org|
|Contact: Yasmin Rustamova|